Stereotaxis Announces Third Quarter Earnings Release Date and Conference Call

Wednesday, October 31, 2007 General News J E 4
ST. LOUIS, Oct. 31 Stereotaxis, Inc.(Nasdaq: STXS) announced today that it will release its financial results forthe third quarter ended September 30, 2007, on Thursday, November 8, 2007before the market opens. The Company will host a conference call and webcaston Thursday, November 8, 2007 at 8:30 a.m. Eastern Time to discuss theCompany's third quarter results and current corporate developments. Thedial-in number for the conference call is 800-218-0204 for domesticparticipants and 303-262-2140 for international participants.

A taped replay of the conference call will also be available beginningapproximately one hour after the call's conclusion and will be available forseven days. This replay can be accessed by dialing 800-405-2236 for domesticcallers and 303-590-3000 for international callers, both using passcode11098126#. The call will also be available on the Internet live and 90 daysthereafter at the following URL:

About Stereotaxis

Stereotaxis designs, manufactures and markets an advanced cardiologyinstrument control system for use in a hospital's interventional surgicalsuite to enhance the treatment of coronary artery disease and arrhythmias. TheStereotaxis System is designed to enable physicians to complete more complexinterventional procedures by providing image guided delivery of catheters andguidewires through the blood vessels and chambers of the heart to treatmentsites. This is achieved using computer-controlled, externally applied magneticfields that govern the motion of the working tip of the catheter or guidewire,resulting in improved navigation, shorter procedure time and reduced x-rayexposure. The core components of the Stereotaxis system have receivedregulatory clearance in the U.S., Europe and Canada.

SOURCE Stereotaxis, Inc.


You May Also Like

View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
Neurobiological Technologies Reports $2.1 Million ...
Pharsight to Present at INFORMS Annual Meeting on ...